These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9527776)

  • 1. Evaluation of the safety and pharmacokinetic profile of a new, pasteurized, human tetanus immunoglobulin administered as sham, postexposure prophylaxis of tetanus.
    Forrat R; Dumas R; Seiberling M; Merz M; Lutsch C; Lang J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):298-305. PubMed ID: 9527776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial [corrected] administration of tetanus toxoid (TT) versus tetanus and reduced diphtheria (Td) in pregnant women.
    Salama MM; Hady OA; Ashour W; Mostafa A; El Alkamy S; El Sayed N; El Yazeed RA
    J Clin Immunol; 2009 Jul; 29(4):524-31. PubMed ID: 19363703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a new equine tetanus immunoglobulin associated with tetanus-diphtheria vaccine.
    Lang J; Kamga-Fotso L; Peyrieux JC; Blondeau C; Lutsch C; Forrat R
    Am J Trop Med Hyg; 2000; 63(5-6):298-305. PubMed ID: 11421382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences on formation of tetanus antibody after simultaneous injection of tetanus immunoglobulin with tetanus vaccine.
    Shin J; Kim J; Song K
    J Korean Med Sci; 2012 Aug; 27(8):934-8. PubMed ID: 22876062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a single intramuscular dose of a tetanus-diphtheria toxoid (Td) vaccine (BR-TD-1001) in healthy Korean adult subjects.
    Hong T; Chung YJ; Kim TY; Kim IH; Choe YK; Lee J; Jeon S; Han S; Yim DS
    Hum Vaccin Immunother; 2015; 11(10):2440-5. PubMed ID: 26091286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
    Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
    Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.
    Pichichero ME; Rennels MB; Edwards KM; Blatter MM; Marshall GS; Bologa M; Wang E; Mills E
    JAMA; 2005 Jun; 293(24):3003-11. PubMed ID: 15933223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tetanus immune globulin interfere with the immune response to simultaneous administration of tetanus-diphtheria vaccine? A comparative clinical trial in adults.
    Dal-Ré R; Gil A; González A; Lasheras L
    J Clin Pharmacol; 1995 Apr; 35(4):420-5. PubMed ID: 7650233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
    Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
    Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group.
    Stojanov S; Liese JG; Bendjenana H; Harzer E; Barrand M; Jow S; Dupuy M; Belohradsky BH
    Pediatr Infect Dis J; 2000 Jun; 19(6):516-21. PubMed ID: 10877165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults].
    Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J
    Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of the new reduced-dose tetanus-diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study.
    Han SB; Rhim JW; Shin HJ; Kim SY; Kim JH; Kim HH; Lee KY; Kim HM; Choi YY; Ma SH; Kim CS; Kim DH; Ahn DH; Kang JH
    J Microbiol Immunol Infect; 2017 Apr; 50(2):207-213. PubMed ID: 26055693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunogenicity and safety of the new tetanus-reduced diphtheria (Td) vaccines (GC1107) in healthy Korean adolescents: a phase II, double-blind, randomized, multicenter clinical trial.
    Rhim JW; Lee KY; Kim SY; Kim JH; Kim HH; Kim HM; Choi YY; Ma SH; Kim DH; Ahn DH; Kang JH
    J Korean Med Sci; 2013 Apr; 28(4):586-92. PubMed ID: 23579367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial.
    Choi UY; Kim KH; Lee J; Eun BW; Kim HM; Lee KY; Kim DH; Ma SH; Lee J; Kim JH
    J Korean Med Sci; 2021 Dec; 36(49):e313. PubMed ID: 34931494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.
    Lee J; Choi JH; Wie SH; Park SH; Choi SM; Lee MS; Kim TH; Lee HJ; Kang JH
    J Korean Med Sci; 2019 Jan; 34(4):e31. PubMed ID: 30686952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Fortner KB; Swamy GK; Broder KR; Jimenez-Truque N; Zhu Y; Moro PL; Liang J; Walter EB; Heine RP; Moody MA; Yoder S; Edwards KM
    Vaccine; 2018 Oct; 36(42):6354-6360. PubMed ID: 30219367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
    Pichichero ME; Latiolais T; Bernstein DI; Hosbach P; Christian E; Vidor E; Meschievitz C; Daum RS
    Pediatr Infect Dis J; 1997 Sep; 16(9):863-70. PubMed ID: 9306481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.